RecruitingNCT05831631

Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors

Immunophenotype Characterization of Circulating and Tumor Infiltrating Immune Cells in Malignant Brain Tumors.


Sponsor

Pietro Mortini, MD, Prof.

Enrollment

200 participants

Start Date

Aug 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to characterize the circulating leukocyte profile and the immune T cells distribution within the tumor in patients with malignant brain tumors and to correlate these findings with the oncological outcome. Participants will be subjected to blood sampling before surgery and for 12 months of follow-up. Additional sampling and analysis will be performed on tumor samples.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study collects blood and tissue samples from people with malignant (cancerous) brain tumors who are having surgery. Researchers want to better understand the immune cells that circulate in the blood versus those that are found inside the tumor itself. This could help scientists develop better immune-based treatments for brain cancer in the future. **You may be eligible if...** - You are 18 or older - You have been diagnosed with a primary or secondary malignant brain tumor - You are already scheduled to have brain surgery, a biopsy, or radiosurgery - You are able to give informed consent **You may NOT be eligible if...** - You do not meet the inclusion criteria above Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTCirculating leukocytes immunophenotype

Blood samples will be tested with flow cytometry in order to characterize leukocyte subpopulations and to evaluate the circulating immunophenotype

DIAGNOSTIC_TESTTumor sampling

Immunohistochemical analysis will be performed on tumor samples in order to characterize immune T cells distribution within the tumor.


Locations(1)

IRCCS San Raffaele Scientific Institute

Milan, Milan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05831631


Related Trials